Migraine Headaches

Neurology·MeSH: Migraine Disorders

Prevalence

15000.0 / 100K

Incidence

1500.0 / 100K/yr

7 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Approved(4)

Drug	Company
divalproex	Teva Pharmaceutical Industries Limited (TEVA)
inFoods® (IBS)	BIOMERICA INC (BMRA)
trudhesa	IPI Legacy Liquidation Co (IMPL)
ubn relief	HEALTHY EXTRACTS INC. (HYEX)

Unknown(1)

Drug	Company
InFoods® platform (other disease targets)	BIOMERICA INC (BMRA)

Phase 4(2)

Drug	Company
Diphenhydramine	UNITED THERAPEUTICS Corp (UTHR)
Haloperidol	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 7 drugs in development for Migraine Headaches across 5 companies.

There are 1 clinical trial targeting Migraine Headaches tracked by BioSniper.

The estimated prevalence of Migraine Headaches is approximately 15000.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.